June 16, 2021
PMLiVE
GSK partners with iTeos Therapeutics on next-gen immuno-oncology drug
British drug-maker will pay $625m upfront for access to iTeos' anti-TIGIT monoclonal antibody... See more »
1,333 Followers on Owler
Taro
Taro is a pharmaceutical company that manufactures and supplies prescription and over-the-counter products for life science and healthcare markets. Read more
CEO
Uday Vijaykumar Baldota
Missing a competitor? Contribute!
BMS is Taro's top competitor. BMS is headquartered in New York, New York, and was founded in 1858. BMS is in the Pharmaceuticals field. BMS generates 6,639% the revenue of Taro.
Weigh-in!
Help the Owler community know moreTrending News for Taro and Taro's Competitors
June 17, 2021
MarketScreener
Taro Pharmaceutical Industries : Annual Report (SEC Filing - 20-F)
(marketscreener.com) Rx oral dosage products •Allergy : OTC oral dosage products ...https://www.marke... See more »
June 17, 2021
Medical Device News Magazine
ACC, HRS, Bristol Myers Squibb-Pfizer Alliance to Transform AFib Care in Underserved Communities
Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a leading cause of str... See more »
Taro Quarterly and Annual Revenue
Coming soon for Taro!
Annual Revenue
$644.8M
Taro's revenue is the ranked 17th among it's top 10 competitors. The top 10 competitors average 31.1B.
Taro Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
These are all the companies that Taro has acquired. Taro's latest acquisition was Aquinox Pharmaceuticals (Canada) Inc in Jul 2020.
Taro Funding History
No recent funding data found related to Taro
Taro Investments
No recent investments found related to Taro
These are all the companies that Taro has invested in. Taro's latest investment was Aquinox Pharmaceuticals (Canada) Inc in Jul 2020.
Taro News
January 27, 2021NewsOk
Fiscal 3Q Earnings Snapshot
HAIFA BAY, Israel (AP) _ Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal thir... See more »
January 21, 2021BioSpace
Taro to Announce Third Quarter Results on January 27, 2021
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financia... See more »
October 28, 2020MarketScreener
Provides Results for September 30, 2020
(marketscreener.com) Taro Pharmaceutical Industries Ltd. today provided unaudited financial results f... See more »
October 28, 2020St Louis Post Dispatch
Fiscal 2Q Earnings Snapshot
HAIFA BAY, Israel (AP) - Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported fiscal seco... See more »
July 29, 2020MarketScreener
Provides Results for Quarter Ended June 30, 2020
(marketscreener.com) Quarter reflects One-Time Charge for Global Resolution with DOJhttps://www.marke... See more »
July 29, 2020St Louis Post Dispatch
Fiscal 1Q Earnings Snapshot
HAIFA BAY, Israel (AP) - Taro Pharmaceutical Industries Ltd. (TARO) on Wednesday reported a fiscal fi... See more »
Taro Press Releases
December 24, 2016Blackbird
Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. - TARO
NEW ORLEANS-(BUSINESS WIRE)-Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney Gener... See more »
December 24, 2016Business Wire India
Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc
Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the ...... See more »
December 24, 2016NPR
Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc
Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announc... See more »
December 19, 2016Blackbird
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Taro Pharmaceutical Industries Ltd. To Contact The Firm Before Imminent Lead Plaintiff Deadline
NEW YORK, Dec. 19, 2016 (GLOBE NEWSWIRE) - Faruqi & Faruqi, LLP, a leading national securities law fi... See more »
December 7, 2016Blackbird
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Taro Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm
LOS ANGELES-(BUSINESS WIRE)-Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit... See more »
June 22, 2016Business Wire India
Taro Announces Resignation of Chief Financial Officer
Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announc... See more »
February 10, 2016PR Newswire
Kamedis and Taro Announce Availability of the Kamedis® Bio-Herbal Dandruff Care System at Walgreens
TEL AVIV, Israel, Feb. 10, 2016 /PRNewswire/ -- Kamedis Inc., a global provider of clinically proven ... See more »
Social Media
Taro Headquarters
Trending Companies
IN THE NEWS
Parsley Energy | Eagle Materials | Suzlon | Carloadexpress | Heathrow | Galaxy ME | Brinker | 500 | Facebook | Triller | Vertex | Nutanix | Home Depot | Splunk | Starbucks | Google | Capitan Mining | Discovery | Bank of Hawaii | Sanofi | Malibu Boats | Hain Celestial | Weatherford | KeyBank | GIMEG | CPS Group LTD | Centene | Bruker | PSEG | Starwood Hotels | Baltcom | OnePlus | Exxon Mobil | 3M | Kensington Capital | GCI Health | T2 | MGM Resorts | Legal & General | Five9 | Exact Sciences | Mccarthy | Noble Mineral | Advanced Micro Devices | DIRECTV | Fortinet | Swedishhospital | Tesla | Korea Fund | BNY Mellon
PEOPLE ALSO VIEWED
Merieux NutriSciences | NanoCellect | Voyager | Heron | Octapharma | Exosome Diagnostics | Roche | iBio | Fedora Pharma | Premier Research | Jurox | Purolite | Theranos | OncoMed Pharmaceuticals | Dynavax | SimilarWeb | CGI | Turkey Hill | EMnify | Radius Networks | Biotheranostics | Rockland Immunochemicals, Inc. | Biolog, Inc. | Encycle Therapeutics | Biological Dynamics | Collective Health | SAIC Motor | Indique | RELIANCE TRENDS | Generali Italia S.p.A
Taro Summary
ABOUT
Overview
Taro is a pharmaceutical company that manufactures and supplies prescription and over-the-counter products for life science and healthcare markets. Taro was founded in 1950. Taro's headquarters is located in Hawthorne, New York, USA 10532. Taro's late...
CEO
Taro's CEO, Uday Vijaykumar Baldota, currently has an approval rating of 78%. Taro's primary competitors are BMS, Celgene & GSK.Website
taro.comFrequently Asked Questions about Taro
When was Taro founded?
Taro was founded in 1950Who is Taro's CEO?
Taro's CEO is Uday Vijaykumar BaldotaHow much revenue does Taro generate?
Taro generates $644.8M in revenueHow much funding does Taro have?
Taro has historically raised $0 in funding
Where is Taro's headquarters?
Taro's headquarters is in Hawthorne New York, USAHow many employees does Taro have?
Taro has 1,407 employeesWho are Taro's competitors?
Taro's top competitors are BMS, Celgene, GSK
